Is it concerning if AST and ALT levels are elevated?

Elevated levels of aspartate aminotransferase (AST, formerly known as serum glutamic-oxaloacetic transaminase or SGOT) and alanine aminotransferase (ALT, formerly known as serum glutamic-pyruvic transaminase or SGPT) — commonly referred to as “AST/ALT” or colloquially as “GOT/GPT” in some regions — are important biochemical markers of hepatocellular injury. While mild, transient elevations may occur due to benign causes such as recent vigorous exercise, certain medications (e.g., statins, acetaminophen, antibiotics), or acute viral illnesses, persistently elevated or markedly increased levels warrant clinical evaluation.

AST and ALT are enzymes predominantly found in liver cells; when hepatocytes are damaged or die, these enzymes leak into the bloodstream, resulting in detectable serum elevations. ALT is more liver-specific than AST, which is also present in cardiac muscle, skeletal muscle, kidneys, and brain. Therefore, an isolated AST elevation may reflect non-hepatic sources, whereas a disproportionate ALT elevation strongly suggests primary liver pathology — such as nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease, viral hepatitis (e.g., hepatitis B or C), autoimmune hepatitis, drug-induced liver injury, or hereditary conditions like hemochromatosis or alpha-1 antitrypsin deficiency.

The degree and pattern of elevation matter clinically. Mild elevations (up to 2–3 times the upper limit of normal) are common and often reversible with lifestyle modification or discontinuation of offending agents. Moderate-to-severe elevations (>5× ULN) or a rising trend over serial testing raise concern for active inflammation, necrosis, or progressive fibrosis. Additional evaluation typically includes a detailed history (alcohol use, medication/supplement exposure, family liver disease, travel), physical examination, and targeted laboratory testing — such as hepatitis serologies, ferritin and iron studies, ceruloplasmin, antinuclear antibody (ANA), anti-smooth muscle antibody (ASMA), and imaging (e.g., abdominal ultrasound or FibroScan®). In select cases, liver biopsy may be indicated.

In summary, elevated AST and ALT are not diagnoses themselves but red flags signaling potential liver dysfunction. They require contextual interpretation and timely follow-up. If your results show persistent or unexplained elevations, consult a hepatologist or gastroenterologist for comprehensive assessment and individualized management.